Lessons from COVID-19 in Asia and the Pacific, ADB’s response, and Asia Pacific Vaccine Access Facility (APVAX)
A conversation with ADB experts
Event | 24 March 2021
Online
Time of event
10.00-11.15 CET
Summary
Developing Asia and the Pacific has been hit hard by the COVID-19 pandemic, threatening hard-won gains in poverty reduction and the achievement of the Sustainable Development Goals – millions of people have been infected with COVID19 and regional economic output contracted for the first time since the 1960’s.
Since the onset of the pandemic, ADB has worked intensively with its developing member countries to combat the pandemic and plan for an effective recovery. This work has been done in close cooperation with a wide range of partners, many from Europe. Private sector engagement has played a vital role in ADB’s response.
This interactive conversation will bring together leading members of ADB’s team to share their experiences and perspectives, one year into the pandemic. The team will also highlight how ADB plans to partner with Europe to assist developing Asia and the Pacific overcome and recover from COVID19. The team will be on hand to discuss ADB’s Asia Pacific Vaccine Access Facility (APVAX), a $9 billion vaccine initiative to assist its developing members in vaccine procurement and distribution.
Moderator
- Robert Schoellhammer, Representative, European Representative Office
ADB team members speaking at the event will include:
- Jia Xinning, Deputy Director General, Strategy, Policy and Partnerships Department
- Patrick Osewe, Chief of Health Sector Group, Sustainable Development and Climate Change Department
- Steven Beck, Advisor (Trade and Supply Chain Finance), Private Sector Operations Department
- Aniruddha Patil, Principal Investment Specialist, Private Sector Operations Department
- Hyun Joo Youn, Senior Results Management Specialist, Strategy, Policy and Partnerships Department
- Robert Boothe, Senior Planning and Policy Economist, Strategy, Policy and Partnerships Department